No deaths linked to administering the EpiVacCorona vaccine have been registered,” the organization said in a statement.
EpiVacCorona is a single-dose synthetic peptide vaccine against COVID-19 developed by the Vector State Research Center of Virology and Biotechnology. It became the second vaccine against the coronavirus infection certified in Russia. The jab was registered in October 2020. According to the data provided by the Vector center, more than 1 mln people have been vaccinated with EpiVacCorona.